Literature DB >> 11988200

Transcatheter patch correction of secundum atrial septal defects.

Eleftherios B Sideris1, Savvas Toumanides, Benjamin Macuil, Hugo Gutierrez-Leonard, Manolis Poursanov, Alexander Sokolov, Spyridon D Moulopoulos.   

Abstract

The efficacy and safety of the transcatheter patch (TP) correction of a secundum atrial septal defect (ASD) was studied acutely and on short-term follow-up in 20 patients, successfully implanted with the device. TPs are made of polyurethane foam and require temporary balloon catheter immobilization on the atrial septum for 48 hours. Eighteen patients were not suitable for disk-device repair. The patient median age and ASD diameter were 37 years and 26 mm, respectively. Eighteen patients had immediate effective ASD occlusion; 2 patients had significant residual shunts. Premature leaks of the supportive balloons were responsible for the residual shunts. One of the patients with residual shunt received a second patch 6 months later with full occlusion. All patients with implants were doing well up to 24 months after implantation. Existing symptoms improved although residual shunts remained; septal anatomy was normalized, with the patched area becoming progressively indistinguishable from the rest of the septum. In conclusion, TP occlusion of secundum ASD is feasible and effective even for defects unsuitable for disk-device repair. The method appears safe acutely and on short-term follow-up, with symptomatic improvement and normalization of septal anatomy.

Entities:  

Mesh:

Year:  2002        PMID: 11988200     DOI: 10.1016/s0002-9149(02)02280-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Total percutaneous correction of a tetralogy of Fallot variant with dominant pulmonary valve stenosis.

Authors:  E B Sideris; B Macuil; S Justiniano; P S Rao
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

2.  Closure of interatrial defects by immediate-release patch.

Authors:  Aliakbar Zeinaloo; Keyhan Sayadpour Zanjani; Bahman Rastkar; Alimohammad Hajizeinali; Bahram Sohrabi; Mahmoud Samadi; Eleftherios B Sideris
Journal:  Pediatr Cardiol       Date:  2012-03-28       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.